Tag - pharmaceuticals

 
 

PHARMACEUTICALS

Japan Times
JAPAN / Science & Health / FOCUS
Mar 8, 2017
New guidelines tackle misuse of antibiotics amid rise of superbugs
Public health officials have begun tackling the misuse and overuse of antibiotics, as the prevalence of superbugs, or bacteria resistant to antibiotics, reaches alarming levels worldwide.
Japan Times
BUSINESS
Mar 7, 2017
Japan pushes for tighter control on drug pricing, crimping big pharma profits
President Donald Trump has pledged to reverse what he describes as "astronomical" drug prices in the United States. Thousands of kilometers away, Japan, long a profit sanctuary for multinational pharmaceutical companies, is taking a similar tack.
WORLD / Science & Health
Jan 9, 2017
Studies find worrying misuse of medicine worldwide
Up to 70 percent of hysterectomies in the United States, a quarter of knee replacements in Spain and more than half the antibiotics prescribed in China are inappropriate, over-used health care, researchers said on Monday.
Japan Times
WORLD / Science & Health
Jul 22, 2016
Scientists hunt 'anti-evolution' drugs in new cancer fight
Scientists are opening a new front in the war on cancer with plans to develop "anti-evolution" drugs to stop tumor cells from developing resistance to treatment.
Japan Times
BUSINESS / Companies
Jun 23, 2016
Tokyo professor's medicine-making molecules bring new tool to pharma
When he realized he was not going to make it as a guitarist, Hiroaki Suga set out to find the origin of life, and ended up creating a new way to develop medicines.
Japan Times
WORLD / Science & Health
May 29, 2016
New incentives are needed to develop antibiotics against superbugs, drugmakers say
Drugmakers are renewing efforts to develop medicines to fight emerging antibiotic-resistant bacteria, but creating new classes of drugs on the scale needed is unlikely to happen without new financial incentives to make the effort worth the investment, companies and industry experts said.
Japan Times
BUSINESS
Feb 8, 2016
Japan takes aim at ballooning drug prices as costs strain health budget
When two of the world's biggest pharmaceutical companies announced a tie-up in Japan, its $78 billion drug industry took note.
BUSINESS / Companies
Feb 3, 2016
Takeda to evaluate Zika vaccine possibilities
Takeda Pharmaceutical Co., Asia's largest drugmaker, has assembled an internal team to look into how it might contribute to vaccine efforts to combat the Zika virus, the mosquito-borne pathogen that is currently spreading through the Americas.
Japan Times
BUSINESS / Companies
Dec 12, 2015
Dow, DuPont agree on $130 billion merger
Chemical titans DuPont and Dow Chemical Co. have agreed to combine in an all-stock merger valued at $130 billion in a first step toward breaking up into three businesses, a move that pleased activist investors and could trigger more consolidation.
BUSINESS / Companies
Nov 19, 2015
Paris attack prompts name holdout Isis Pharmaceuticals to finally rebrand
The terrorist attacks in Paris may have finally spurred a brand change for Isis Pharmaceuticals Inc., a drugmaker that until now has steadfastly held on to its name even as the militant group rose in prominence in the Middle East.
WORLD / Science & Health
Oct 8, 2015
Scientists call for urgent trials to judge flu drugs for pandemics
Scientists still don't know if two commonly used flu drugs — Roche's Tamiflu and GlaxoSmithKline's Relenza — really work in seasonal or pandemic flu outbreaks and say robust clinical trials are urgently needed to find out.
Japan Times
BUSINESS
Oct 6, 2015
Tentative TPP rewrites trade rules for autos, drugs, produce, rice and IP, but faces legislative OKs
The tentative agreement on trade negotiated by a dozen Pacific Rim nations will slightly pry open Japan's famously closed rice market, protect brand-name drugs from generic competitors for at least five years and lower tariffs on automobiles.
WORLD / Science & Health
Jun 18, 2015
New drug compound may beat malaria with single $1 dose
Scientists have discovered a new anti-malarial compound that could treat patients with a single $1 dose, including those with strains of the mosquito-borne disease that are resistant to current drugs.
Japan Times
JAPAN / Science & Health
Jun 2, 2015
Some experts doubt shift to generic drugs is best prescription for health care system
In a desperate bid to stem the rise in health care costs, the government is reining in one of its biggest medical outlays: prescription drugs.
EDITORIALS
May 29, 2015
The risks of medical deregulation
A new system by which patients can request drugs and treatments not yet approved in Japan carries significant risks.
Japan Times
BUSINESS / Markets
Apr 3, 2015
Japan bubble alert found in drug stock rally that won't quit
This year's Japanese stock rally has a surprise leader: pharmaceutical companies, which tend to lag behind the market when it gains.

Longform

Sumadori Bar on Shibuya Ward's main Center Gai street targets young customers who prefer low-alcohol drinks or abstain altogether.
Rethinking that second drink: Japan’s Gen Z gets ‘sober curious’